Biopharmaceuticals
Generics
Litigation
Licensing
News Release - September 28, 2017
Amgen And AbbVie Agree To Settlement Allowing Commercialization Of AMGEVITA(TM)
Source: Amgen
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.